•  
  •  
 

References

Kementerian Kesehatan RI. Laporan Hasil Riset Kesehatan Dasar (Riskesdas) Indonesia tahun 2018. Jakarta: Kementerian Kesehatan RI; 2018. hal.182–3. 2. Tahapary DL, Soewondo P. Burden of metabolic diseases in Indonesia: an even more critical issue during COVID-19 pandemic. Med J Indones. 2020;29(4):347-9.3. Suastika K. The challenges of metabolic disorders in Indonesia: focus on metabolic syndrome, prediabetes, and diabetes. Med J Indones. 2020;29(4):350–3. 4. Ahmed SH, Chowdhury TA, Hussain S, Syed A, Karamat A, Helmy A, et al. Ramadan and diabetes: a narrative review and practice update. Diabetes Ther. 2020;11(11):2477–520. 5. International Diabetes Federation (IDF) and Diabetes and Ramadan (DaR) International Alliance. Diabetes and Ramadan: practical guidelines 2021. Brussel, Belgium: IDF; 2021. 6. Ahmed SH, Chowdhury TA, Hussain S, Syed A, Karamat A, Helmy A, et al. Ramadan and diabetes: a narrative review and practice update. Diabetes Ther. 2020;2020:1-44.7. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26(6):1902–12. 8. Unger R, Cherrington A. Glucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover. J Clin Invest. 2012;122:4–12. 9. Harbuwono DS, Kurniawan F, Sudarsono NC, et al. The impact of Ramadan fasting on glucose variability in type 2 diabetes mellitus patients on oral anti diabetic agents. PLoS One. 2020;15(6):e0234443.10. Gustaviani R, Soewondo P, Semiardji G, Sudoyo AW. The influence of calorie restriction during the Ramadan fast on serum fructosamine and the formation of beta hydroxybutirate in type 2 diabetes mellitus patients. Acta Med Indones. 2004;36(3):136–41. 11. Tahapary DL, Astrella C, Kristanti M, Harbuwono DS, Soewondo P. The impact of Ramadan fasting on metabolic profile among type 2 diabetes mellitus patients: A meta-analysis. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(5):1559-70.12. Ismail S, Manaf R, Mahmud A. Comparison of time-restricted feeding and islamic fasting: A scoping review. East Mediterr Heal J. 2019;25(4):239–45. 13. Albosta M, Bakke J. Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians. Clin Diabetes Endocrinol. 2021;7(1):3. 14. Wilkinson MJ, Manoogian ENC, Zadourian A, Lo H, Fakhouri S, Shoghi A, et al. Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome. Cell Metab. 2020;31(1):92-104. 15. Zubrzycki A, Cierpka-Kmiec K, Kmiec Z, Wronska A. The role of low-calorie diets and intermittent fasting in the treatment of obesity and type-2 diabetes. J Physiol Pharmacol. 2018;69(5):30683819.16. Anton SD, Moehl K, Donahoo WT, Marosi K, Lee SA, Mainous AG, et al. Flipping the metabolic switch: understanding and applying the health benefits of fasting. Obesity (Silver Spring). 2018;26(2):254-268.17. Lichtash C, Fung J, Ostoich KC, Ramos M. Therapeutic use of intermittent fasting and ketogenic diet as an alternative treatment for type 2 diabetes in a normal weight woman: a 14-month case study. BMJ Case Rep. 2020;13:e234223. 18. Furmli S, Elmasry R, Ramos M, Fung J. Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin. BMJ Case Rep. 2018;2018:bcr221854. 19. Burkewitz K, Weir HJM, Mair WB. AMPK as a Pro-longevity Target. Exp Suppl. 2016;107:227–56

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.